DMAA
Drugs Made In·NASDAQ
--
--(--)
--
--(--)
4.38 / 10
Netural
Technical evaluation yields a 4.38/10 composite score, denoting mixed technical signals. Optimistic indicators comprise MACD Death Cross and Marubozu White, while MACD Golden Cross and RSI Overbought warrant caution. The technical perspective remains neutral with watchful bias.
Analysis Checks(2/4)
RSI Overbought
Score1.84/10
Win Rate40.00%
Hist. Signals20
Avg Return0.00%
Score1.84/10
Win Rate40.00%
Hist. Signals20
Avg Return0.00%
MACD Golden Cross
Score2.01/10
Win Rate40.00%
Hist. Signals15
Avg Return0.02%
Score2.01/10
Win Rate40.00%
Hist. Signals15
Avg Return0.02%
MACD Death Cross
Score6.63/10
Win Rate64.29%
Hist. Signals14
Avg Return0.04%
Score6.63/10
Win Rate64.29%
Hist. Signals14
Avg Return0.04%
Marubozu White
Score7.05/10
Win Rate63.46%
Hist. Signals52
Avg Return0.06%
Score7.05/10
Win Rate63.46%
Hist. Signals52
Avg Return0.06%
RSI Overbought
Score1.84/10
Win Rate40.00%
Hist. Signals20
Avg Return0.00%
Score1.84/10
Win Rate40.00%
Hist. Signals20
Avg Return0.00%
MACD Death Cross
Score6.63/10
Win Rate64.29%
Hist. Signals14
Avg Return0.04%
Score6.63/10
Win Rate64.29%
Hist. Signals14
Avg Return0.04%
MACD Golden Cross
Score2.01/10
Win Rate40.00%
Hist. Signals15
Avg Return0.02%
Score2.01/10
Win Rate40.00%
Hist. Signals15
Avg Return0.02%
Marubozu White
Score7.05/10
Win Rate63.46%
Hist. Signals52
Avg Return0.06%
Score7.05/10
Win Rate63.46%
Hist. Signals52
Avg Return0.06%
What is the current technical signals for DMAA?
- DMAA presents a Netural setup with a Technical Score of 4.38/10. Key technical indicators highlight an RSI of 61.06 and a MACD of -0.00, with the trend anchored by the 50-Day SMA at 10.38. Traders should monitor key support at 10.42 and resistance at 10.44.
